Literature DB >> 14747056

Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma.

A Kosunen1, K Ropponen, J Kellokoski, M Pukkila, J Virtaniemi, H Valtonen, E Kumpulainen, R Johansson, R Tammi, M Tammi, J Nuutinen, V-M Kosma.   

Abstract

Several malignant tumours accumulate hyaluronan (HA), a matrix component suggested to promote cancer cell growth and migration. The expression and prognostic value of HA was analysed in a cohort of 151 oral squamous cell carcinoma (SCC) patients with adequate archival tumour material and follow-up data. The tumour samples were stained using a biotinylated HA-specific probe. Normal squamous epithelium showed a strong and homogeneously distributed staining for HA. The most superficial layers were HA-negative. In moderate (n=11) and high grade (n=16) dysplasias an irregular HA staining was observed around invasive cancer. Malignant transformation in oral squamous cell epithelium changed the staining toward irregular with focal reduction of HA. The well (n=92) or moderately differentiated (n=47) carcinomas had a strong HA staining intensity. In poorly differentiated tumours (n=12) the HA staining was weaker and mainly intracellular. The stromal tissue showed usually moderate (n=69) or strong (n=67) HA staining intensity with no statistically significant correlation with the degree of tumour differentiation. At the end of the follow-up (median 52 months) 66 (43%) patients had died because of an oral SCC. A significant difference in overall survival (OS) and disease free survival (DFS) (P=0.0002 and 0.0020, respectively) was noticed between the patients with the different epithelial staining patterns for HA. The reduction of HA staining was associated with poor survival. In Cox's multivariate analysis HA staining was a significant independent predictor of OS (P=0.011) and DFS (P=0.013). These results suggest that HA is a prognostic marker in oral squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747056     DOI: 10.1016/j.oraloncology.2003.08.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  18 in total

1.  Chronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis.

Authors:  Hanna Siiskonen; Kari Törrönen; Timo Kumlin; Kirsi Rilla; Markku I Tammi; Raija H Tammi
Journal:  J Histochem Cytochem       Date:  2011-08-10       Impact factor: 2.479

2.  High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.

Authors:  Matti Pukkila; Ari Kosunen; Kirsi Ropponen; Jukka Virtaniemi; Jari Kellokoski; Eero Kumpulainen; Risto Pirinen; Juhani Nuutinen; Risto Johansson; Veli-Matti Kosma
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

Review 3.  Prognostic biological features in neck dissection specimens.

Authors:  Julia A Woolgar; Asterios Triantafyllou; James S Lewis; Jennifer Hunt; Michelle D Williams; Robert P Takes; Lester D R Thompson; Pieter J Slootweg; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-15       Impact factor: 2.503

Review 4.  Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.

Authors:  Hideo Shigeishi; Koichiro Higashikawa; Masaaki Takechi
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-28       Impact factor: 4.553

5.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

6.  Analysis of the expression of hyaluronan in intraductal and invasive carcinomas of the breast.

Authors:  Maria Daniela Corte; Luis Ovidio González; Sara Junquera; Miguel Bongera; Maria Teresa Allende; Francisco José Vizoso
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-07       Impact factor: 4.553

7.  Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells.

Authors:  Suniti Misra; Lina M Obeid; Yusuf A Hannun; Susumu Minamisawa; Franklin G Berger; Roger R Markwald; Bryan P Toole; Shibnath Ghatak
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

8.  Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.

Authors:  Sören Twarock; Till Freudenberger; Eva Poscher; Guang Dai; Katharina Jannasch; Christian Dullin; Frauke Alves; Klaus Prenzel; Wolfram T Knoefel; Nikolas H Stoecklein; Rashmin C Savani; Bernhard Homey; Jens W Fischer
Journal:  Mol Cancer       Date:  2011-03-23       Impact factor: 27.401

9.  Hyaluronidases and hyaluronan synthases expression is inversely correlated with malignancy in lung/bronchial pre-neoplastic and neoplastic lesions, affecting prognosis.

Authors:  V K de Sá; T P Rocha; Al Moreira; F A Soares; T Takagaki; L Carvalho; A G Nicholson; V L Capelozzi
Journal:  Braz J Med Biol Res       Date:  2015-08-28       Impact factor: 2.590

10.  Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma.

Authors:  Hanna Siiskonen; Mari Poukka; Kristiina Tyynelä-Korhonen; Reijo Sironen; Sanna Pasonen-Seppänen
Journal:  BMC Cancer       Date:  2013-04-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.